Predictive Oncology (POAI) announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding shares of common stock. The reverse stock split will become effective at 12:01 a.m. on Tuesday, September 30, 2025. Predictive Oncology’s common stock will continue to be traded on Nasdaq under the symbol POAI and will begin trading on a reverse split-adjusted basis when the market opens on Tuesday, September 30, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on POAI:
- Predictive Oncology Approves New Equity Incentive Plan
- Predictive Oncology, Every Cure announce strategic collaboration
- Predictive Oncology Sells Shares to Accredited Investor
- Predictive Oncology Reports Significant Losses Amid Financial Challenges
- Predictive Oncology reports Q2 EPS (22c) vs. (53c) last year